Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease
- Substances:GolimumabGuselkumab
Hungary- Participants:18–64 years · 65+ years
- Substances:Golimumab
Rare diseases
Investigational molecules
Locations
HungaryRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
HungaryContraceptive efficacy, safety and tolerability of drospirenone 4 mg (LPRI‑CF113) in healthy women of reproductive age over 13 cycles
HungaryStudy of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
Hungary
HungaryLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
HungaryA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
HungaryStudy of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)
HungaryEfficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma
HungaryLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
HungaryOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
HungaryZenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
HungaryTell us about your condition – we search every trial in Europe and connect you with the right site.